PENDOLINO, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 730
EU - Europa 163
AS - Asia 89
SA - Sud America 8
AF - Africa 6
Totale 996
Nazione #
US - Stati Uniti d'America 727
IT - Italia 62
SE - Svezia 44
IN - India 31
SG - Singapore 30
CN - Cina 22
FI - Finlandia 19
BG - Bulgaria 12
DE - Germania 7
TG - Togo 6
FR - Francia 4
AR - Argentina 3
BR - Brasile 3
CA - Canada 3
GB - Regno Unito 3
IE - Irlanda 3
PL - Polonia 3
HK - Hong Kong 2
RO - Romania 2
UA - Ucraina 2
BE - Belgio 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
PE - Perù 1
VE - Venezuela 1
Totale 996
Città #
Fairfield 113
Chandler 86
Houston 50
Ashburn 48
Woodbridge 48
Seattle 43
Cambridge 42
Dearborn 34
Wilmington 29
Rome 26
Princeton 19
San Paolo di Civitate 19
Singapore 19
Plano 15
Lawrence 14
Ann Arbor 13
New York 13
Beijing 12
Sofia 12
Helsinki 10
Andover 8
Milan 8
Millbury 8
San Diego 8
Boston 6
Lomé 6
Phoenix 6
Norwalk 5
Dublin 3
Federal 3
Nanjing 3
Centro 2
Falls Church 2
Hong Kong 2
Los Angeles 2
Pisa 2
Toronto 2
Warsaw 2
Brussels 1
Budapest 1
Bühl 1
Cachoeiro de Itapemirim 1
Chicago 1
Dallas 1
Des Moines 1
Fremont 1
Guangzhou 1
Hanover 1
Harbin 1
Hebei 1
Huzhou 1
Islington 1
Jacksonville 1
Jinan 1
Lima 1
Mannheim 1
Mcallen 1
Nanning 1
Ottawa 1
Paris 1
Polska 1
Quzhou 1
Redwood City 1
Ridder 1
Salerno 1
Santa Clara 1
Simi Valley 1
Taranto 1
Totale 773
Nome #
Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases 96
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension. 90
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement 84
Citrullination and autoimmunity. 80
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren’s syndrome patients and correlates with focus score and disease activity 77
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus 75
Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes. 73
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis 68
IL-18 Serum Level in Adult Onset Still’s Disease: A Marker of Disease Activity 66
New autoantigens in the antiphospholipid syndrome 64
Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative for conventional tests 58
Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor 54
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 51
Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus 46
Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features 43
A COMPLETE REMISSION LASTING AT LEAST ONE YEAR INFLUENCES THE OUTCOME IN PATIENTS AFFECTED BY SLE: RESULTS FROM A LARGE MONOCENTRIC COHORT 39
Totale 1.064
Categoria #
all - tutte 3.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020192 0 0 0 8 26 45 31 31 23 17 7 4
2020/202180 5 9 4 1 1 2 0 5 23 20 10 0
2021/2022200 2 14 16 14 16 5 4 21 6 13 56 33
2022/2023236 37 71 17 26 23 19 1 16 17 3 5 1
2023/202497 6 16 3 4 4 26 2 14 0 9 9 4
2024/202527 11 4 12 0 0 0 0 0 0 0 0 0
Totale 1.064